211 related articles for article (PubMed ID: 36452305)
1. Phosphatidylinositol 4-kinase is a viable target for the radical cure of
Ji S; Galon EM; Amer MM; Zafar I; Yanagawa M; Asada M; Zhou J; Liu M; Xuan X
Front Cell Infect Microbiol; 2022; 12():1048962. PubMed ID: 36452305
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the Antimalarial MMV390048 against
Ji S; Galon EM; Rizk MA; Yi Y; Zafar I; Li H; Ma Z; Iguchi A; Asada M; Liu M; Xuan X
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0057422. PubMed ID: 35924942
[TBL] [Abstract][Full Text] [Related]
3. Combination of Clofazimine and Atovaquone as a Potent Therapeutic Regimen for the Radical Cure of Babesia microti Infection in Immunocompromised Hosts.
Tuvshintulga B; Sivakumar T; Nugraha AB; Ahedor B; Batmagnai E; Otgonsuren D; Liu M; Xuan X; Igarashi I; Yokoyama N
J Infect Dis; 2022 Jan; 225(2):238-242. PubMed ID: 34664651
[TBL] [Abstract][Full Text] [Related]
4. Clofazimine, a Promising Drug for the Treatment of Babesia microti Infection in Severely Immunocompromised Hosts.
Tuvshintulga B; Vannier E; Tayebwa DS; Gantuya S; Sivakumar T; Guswanto A; Krause PJ; Yokoyama N; Igarashi I
J Infect Dis; 2020 Aug; 222(6):1027-1036. PubMed ID: 32310272
[TBL] [Abstract][Full Text] [Related]
5. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ
Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477
[TBL] [Abstract][Full Text] [Related]
6. Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone.
Lawres LA; Garg A; Kumar V; Bruzual I; Forquer IP; Renard I; Virji AZ; Boulard P; Rodriguez EX; Allen AJ; Pou S; Wegmann KW; Winter RW; Nilsen A; Mao J; Preston DA; Belperron AA; Bockenstedt LK; Hinrichs DJ; Riscoe MK; Doggett JS; Ben Mamoun C
J Exp Med; 2016 Jun; 213(7):1307-18. PubMed ID: 27270894
[TBL] [Abstract][Full Text] [Related]
7. Tafenoquine-Atovaquone Combination Achieves Radical Cure and Confers Sterile Immunity in Experimental Models of Human Babesiosis.
Vydyam P; Pal AC; Renard I; Chand M; Kumari V; Gennaro JC; Mamoun CB
J Infect Dis; 2024 Jan; 229(1):161-172. PubMed ID: 38169301
[TBL] [Abstract][Full Text] [Related]
8.
Rizk MA; El-Sayed SAE; Igarashi I
Pathog Glob Health; 2023 May; 117(3):315-321. PubMed ID: 36172647
[TBL] [Abstract][Full Text] [Related]
9. Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report.
Vyas JM; Telford SR; Robbins GK
Clin Infect Dis; 2007 Dec; 45(12):1588-90. PubMed ID: 18190320
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Two New Endochin-like Quinolones, ELQ-596 and ELQ-650, in Experimental Mouse Models of Human Babesiosis.
Vydyam P; Chand M; Pou S; Winter RW; Liebman KM; Nilsen A; Doggett JS; Riscoe MK; Ben Mamoun C
ACS Infect Dis; 2024 Apr; 10(4):1405-1413. PubMed ID: 38563132
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
Checa R; Montoya A; Ortega N; González-Fraga JL; Bartolomé A; Gálvez R; Marino V; Miró G
Parasit Vectors; 2017 Mar; 10(1):145. PubMed ID: 28292316
[TBL] [Abstract][Full Text] [Related]
12. Impact of Babesia microti infection on the initiation and course of pregnancy in BALB/c mice.
Tołkacz K; Rodo A; Wdowiarska A; Bajer A; Bednarska M
Parasit Vectors; 2021 Mar; 14(1):132. PubMed ID: 33653384
[TBL] [Abstract][Full Text] [Related]
13. Babesiosis in humans: a treatment review.
Weiss LM
Expert Opin Pharmacother; 2002 Aug; 3(8):1109-15. PubMed ID: 12150690
[TBL] [Abstract][Full Text] [Related]
14. Effective Therapy Targeting Cytochrome
Chiu JE; Renard I; Pal AC; Singh P; Vydyam P; Thekkiniath J; Kumar M; Gihaz S; Pou S; Winter RW; Dodean R; Frueh L; Nilsen AC; Riscoe MK; Doggett JS; Mamoun CB
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0066221. PubMed ID: 34152821
[TBL] [Abstract][Full Text] [Related]
15. Epitope profiling of monoclonal antibodies to the immunodominant antigen BmGPI12 of the human pathogen
Chand M; Choi JY; Pal AC; Singh P; Kumari V; Thekkiniath J; Gagnon J; Timalsina S; Gaur G; Williams S; Ledizet M; Mamoun CB
Front Cell Infect Microbiol; 2022; 12():1039197. PubMed ID: 36506011
[TBL] [Abstract][Full Text] [Related]
16. 17-DMAG inhibits the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice.
Guswanto A; Nugraha AB; Tuvshintulga B; Tayebwa DS; Rizk MA; Batiha GE; Gantuya S; Sivakumar T; Yokoyama N; Igarashi I
Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):104-111. PubMed ID: 29499568
[TBL] [Abstract][Full Text] [Related]
17. Optimization of an Evaluation Method for Anti-Babesia microti Drug Efficacy.
Yin M; Zhang HB; Tao Y; Yao JM; Liu H; Win HH; Huo LL; Jiang B; Chen JX
Acta Trop; 2022 Jan; 225():106179. PubMed ID: 34627758
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary analysis of Babesia vulpes and Babesia microti-like parasites.
Lee S; Hong Y; Chung DI; Jang HK; Goo YK; Xuan X
Parasit Vectors; 2022 Nov; 15(1):404. PubMed ID: 36329533
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of inhibitory effect of redox-active antimalarial drug against Babesia microti in mice.
Szymczak J; Kozłowska J; Doligalska M
Ann Parasitol; 2017; 63(3):223–227. PubMed ID: 29274217
[TBL] [Abstract][Full Text] [Related]
20. A conserved protein of Babesia microti elicits partial protection against Babesia and Plasmodium infection.
Wang Y; Zhang Q; Zhang W; Chen J; Dai J; Zhou X
Parasit Vectors; 2023 Aug; 16(1):306. PubMed ID: 37649042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
